Live Breaking News & Updates on Theta License|Page 1

Stay updated with breaking news from Theta license. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

IDEAYA Biosciences Announces Clearance of IND Application for Pol Theta Helicase Development Candidate GSK101 (IDE705)

/PRNewswire/ IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted. ....

Yujiros Hata , Ramon Kemp , Werner Helicase , Biosciences Inc , Global Head Of Oncology Early Development , Exchange Commission , Drug Administration , Pol Theta Helicase Inhibitor , Investigational New Drug , Pol Theta Helicase , Pol Theta , Vice President , Global Head , Oncology Early Development , Chief Executive Officer , Theta License , Chief Financial , Ideaya Biosciences ,